Author

Gemma K. Kinsella

Technological University DublinORCID 0000-0002-6329-5841Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Adam T. McCormackiD· 1 shared Anna G. RobertsiD· 1 shared Barry James RyaniD· 1 shared David A. BakeriD· 1 shared David C. HornigoldiD· 1 shared Ebin K. BabyiD· 1 shared Elisa BenettiiD· 1 shared Elpida TsonouiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Adam T. McCormackORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Extraordinary activation of CALB by alkylammonium ions: a new paradigm for activity enhancement of enzymes

Rangasamy Savitha, Ebin K. Baby, Gemma K. Kinsella, Kieran J. M. Nolan, Barry James Ryan, GARY T. M. HENEHAN

This paper identifies alkylammonium ions as a new class of enzyme activators that significantly enhance CALB activity and stability through specific binding sites.

bioRxiv · Apr 18, 2025 · PreprintBioengineering

Prex1 controls glucose homeostasis by limiting glucose uptake and mitochondrial metabolism in liver through GEF-independent regulation of Gpr21

Julia Y. Chu, Elpida Tsonou, Polly A. Machin, Kirsty MacLellan‐Gibson, Anna G. Roberts, Stephen A. Chetwynd, Adam T. McCormack, John C. Stephens, Elisa Benetti, Gemma K. Kinsella, David A. Baker, David C. Hornigold, Heidi C. E. Welch

This study shows Prex1 regulates glucose homeostasis by reducing glucose uptake and mitochondrial metabolism in the liver, independent of its catalytic activity, through Gpr21 inhibition.

bioRxiv · Apr 14, 2025 · PreprintPhysiology